Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 2 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer.
Cells. 2020 Jun 28;9(7):1573. doi: 10.3390/cells9071573.
Cells. 2020.
PMID: 32605193
Free PMC article.
Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells.
Juliá EP, Amante A, Pampena MB, Mordoh J, Levy EM.
Juliá EP, et al.
Front Immunol. 2018 Sep 20;9:2140. doi: 10.3389/fimmu.2018.02140. eCollection 2018.
Front Immunol. 2018.
PMID: 30294328
Free PMC article.
Item in Clipboard
High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients.
Mandó P, Rizzo M, Roberti MP, Juliá EP, Pampena MB, Pérez de la Puente C, Loza CM, Ponce C, Nadal J, Coló FA, Mordoh J, Levy EM.
Mandó P, et al. Among authors: julia ep.
Onco Targets Ther. 2018 May 17;11:2901-2910. doi: 10.2147/OTT.S160911. eCollection 2018.
Onco Targets Ther. 2018.
PMID: 29844687
Free PMC article.
Item in Clipboard
Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients.
Juliá EP, Mandó P, Rizzo MM, Cueto GR, Tsou F, Luca R, Pupareli C, Bravo AI, Astorino W, Mordoh J, Martín C, Levy EM.
Juliá EP, et al.
Cancer Immunol Immunother. 2019 Oct;68(10):1585-1596. doi: 10.1007/s00262-019-02391-z. Epub 2019 Sep 12.
Cancer Immunol Immunother. 2019.
PMID: 31515670
Item in Clipboard
Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.
Rocca YS, Roberti MP, Juliá EP, Pampena MB, Bruno L, Rivero S, Huertas E, Sánchez Loria F, Pairola A, Caignard A, Mordoh J, Levy EM.
Rocca YS, et al. Among authors: julia ep.
Front Immunol. 2016 Oct 10;7:413. doi: 10.3389/fimmu.2016.00413. eCollection 2016.
Front Immunol. 2016.
PMID: 27777574
Free PMC article.
Item in Clipboard
Cite
Cite